You are here

P&T News

April 21

Company touts lowest-priced injectable biologic psoriasis treatment
Drug developer keeps details under wraps
Discovery could lead to changes in disease management

April 20

Moderates and conservatives try to make a deal
Companies and PBMs work hand-in-hand to keep prices high, lawyer argues
Primary endpoints missed in lung and breast cancer studies

April 19

Agency wants health care accreditors to reveal what they find
Group said to have close ties to PhRMA
Authors propose lower costs and more cardiologist visits

April 18

Agency aims to revise payment systems
Rare disease treatments cost mega-bucks
Two-thirds of respondents said they would use the drug if prescribed by a physician
First immunotherapy for patients unable to receive cisplatin
Only treatment for patients with or without DME

Pages